SANUWAVE Health (SNWV) Stock Price, News & Analysis

Company Overview

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Key Stats

• Today's Range: $29.50 to $32.04
• 50-Day Range: $25.77 to $34.28
• 52-Week Range: $5.17 to $39.50
• Volume: 56,451 shs
• Average Volume: 34,774 shs
• Market Capitalization: $265.15 million
• P/E Ratio: 3.72
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SNWV Stock Analysis - Frequently Asked Questions

How have SNWV shares performed this year?

SANUWAVE Health's stock was trading at $23.00 at the beginning of the year. Since then, SNWV shares have increased by 34.7% and is now trading at $30.99.
View the best growth stocks for 2025 here.

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) issued its earnings results on Monday, November, 16th. The company reported ($7.50) earnings per share for the quarter, missing analysts' consensus estimates of ($3.75) by $3.75. The business earned $1.97 million during the quarter. SANUWAVE Health had a negative net margin of 1.33% and a negative trailing twelve-month return on equity of 23.83%.

When did SANUWAVE Health's stock split?

SANUWAVE Health shares reverse split before market open on Friday, October 18th 2024. The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of SANUWAVE Health?

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SANUWAVE Health investors own include Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and VBI Vaccines (VBIV).

Company Calendar

• Last Earnings: 11/16/2020
• Today: 6/13/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:SNWV
• CIK: 1417663
• Web: www.sanuwave.com
• Phone: (770) 419-7525
• Fax: 770-419-8634
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($4.56)
• Trailing P/E Ratio: 3.72
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.81 million
• Net Margins: -1.33%
• Pretax Margin: -1.31%
• Return on Equity: -23.83%
• Return on Assets: -20.60%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.12
• Quick Ratio: 0.08

Sales & Book Value

• Annual Sales: $36.19 million
• Price / Sales: 7.33
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($14.02) per share
• Price / Book: -2.21

Miscellaneous

• Outstanding Shares: 8,556,000
• Free Float: 5,418,000
• Market Cap: $265.15 million
• Optionable: Not Optionable
• Beta: 1.19